Track topics on Twitter Track topics that are important to you
Cellectis is the worldwide leader in the research, development and commercialization of rational genome engineering technologies. Cellectis proprietary technologies and platform are based upon a naturally occurring class of DNA endonucleases, the Meganucleases and DNA recombination.The DNA recognition and function of Meganucleases can be used to target a unique DNA break at a specific location within living cells. Meganucleases are acting in a site-directed fashion by inducing a highly efficient targeted DNA recombination. Rational genome engineering based on DNA recombination and Meganucleases represents an enabling technology that can be applicable to biotechnological R&D and industrial applications. More.
102 route de Noisy
Phone: 33 1 41 83 99 00
Fax: 33 1 41 83 99 03
The bitter patent feud over CRISPR , a gene-editing tool with unprecedented potential, continues in the United States. Meanwhile, French biotech Cellectis is staking a claim to the technology in Europ...
The FDA has cleared Cellectis to resume testing an experimental “off the shelf” type of cell therapy, so long as it follows a new set of measures meant to quell the safety concerns that caused the...
It is easy to forget the very real dangers that CAR-T treatment present to patients after Novartis and Gilead both successfully scored approvals on the back of impressive data, and with Juno Therapeut...
Paris – amazingly it’s now 3 years since we interviewed Cellectis (NASDAQ: $CLLS) CEO André Choulika and CSO Philippe Duchateau…
The early-stage clinical trial that will evaluate the efficacy and safety of UCART123, Cellectis' chimeric antigen receptor T -More-
ENDPOINTS NEWS | The FDA has forced Cellectis to slam the brakes on two clinical trials of its off-the-shelf-version of a CAR-T therapy after their first patient was killed by a lethally toxic react...
Cellectis, a clinical─stage biopharmaceutical company focused on developing immunotherapies based on gene─edited CAR T─cells (UCART), announced that the first patient with Blastic Plasmacytoid
US regulators have placed on hold studies of French drugmaker Cellectis’ CAR-T therapy following a patient fatality.
Cellectis is a pioneer in the field of genome engineering. The company designs and markets innovative tools, meganucleases. These molecular scissors enable targeted modifications ...
Cellectis stem cells, is a business unit within the Cellectis group and is a global leader in stem cell technology. Cellectis stem cells, created in November 2011 from Cellartis A...
Cellectis bioresearch was incorporated as a subsidiary of Cellectis SA (Alternext: ALCLS) in June 2008. It provides life science researchers with ready-to-use research tools for genome customization. ...
Cellectis S.A. is a world leader in genome engineering and genome surgery. The company focuses on developing and producing custom meganucleases for use in in vivo genome surgery a...
Cellectis is a pioneer in the field of genome engineering. The company designs and markets innovative tools -meganucleases. These molecular scissors enable targeted modifications to DNA, with applicat...
We have published hundreds of Cellectis SA news stories on BioPortfolio along with dozens of Cellectis SA Clinical Trials and PubMed Articles about Cellectis SA for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Cellectis SA Companies in our database. You can also find out about relevant Cellectis SA Drugs and Medications on this site too.
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...
DNA sequencing is the process of determining the precise order of nucleotides within a DNA molecule. During DNA sequencing, the bases of a small fragment of DNA are sequentially identified from signals emitted as each fragment is re-synthesized from a ...
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...